MedPath

Bacitracin Zinc and Polymyxin B Sulfate

Approved
Approval ID

064c3812-c664-40e3-a21b-b841757600d0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bacitracin Zinc and Polymyxin B Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-1199
Application NumberANDA064028
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bacitracin Zinc and Polymyxin B Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateNovember 30, 2010
FDA Product Classification

INGREDIENTS (4)

POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 g
Code: 19371312D4
Classification: ACTIB
BACITRACIN ZINCActive
Quantity: 500 [USP'U] in 1 g
Code: 89Y4M234ES
Classification: ACTIB
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Bacitracin Zinc and Polymyxin B Sulfate - FDA Drug Approval Details